Model-Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen
CLINICAL PHARMACOLOGY & THERAPEUTICS（2024）
Key words
Treatment Discontinuation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined